DOI : 10.1055/s-00000094

Zeitschrift für Gastroenterologie

Issue 05 · Volume 57 · May 2019 DOI: 10.1055/s-009-43057

Österreichische Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH)
52. Jahrestagung & 30. Fortbildungskurs der Österreichischen Gesellschaft für Gastroenterologie & Hepatologie (ÖGGH)
Innsbruck, 13.–15.06.2019

Kongresspräsident: Univ.-Prof. Dr. Herbert Tilg Kongresssekretäre: Univ-Prof. Dr. Robert Koch Univ.-Prof. Dr. Heinz Zoller Fortbildungskurs: Univ.-Prof. Dr. Peter Ferenci Prim. Univ.-Prof. Dr. Michael Gschwantler
Abstracts (HTML) List of Authors
P42
Scheiner, B; Northup, PG; Gruber, AB; Leitner, G; Quehenberger, P; Thaler, J; Ay, C; Trauner, M; Reiberger, T; Lisman, T; Mandorfer, M: The impact of ABO blood type on VWF and factor VIII levels and the prevalence of portal vein thrombosis in patients with advanced chronic liver disease
P43
Scheiner, B; Stättermayer, AF; Schwabl, P; Bucsics, T; Paternostro, R; Bauer, D; Schmidt, R; Ferlitsch, A; Peck-Radosavljevic, M; Pinter, M; Trauner, M; Reiberger, T; Ferenci, P; Mandorfer, M: Impact of HSD17B13 rs72613567 genotype on hepatic decompensation and mortality in patients with portal hypertension
P44
Chromy, D; Schmidt, R; Mayer, F; Bauer, D; Simbrunner, B; Schmidbauer, C; Gschwantler, M; Ferenci, P; Trauner, M; Mandorfer, M; Reiberger, T: HCV-Scenario over the last decade at the Medical University Vienna: 6023 viremic HCV(+) patients identified with an 'overestimated' number of 3499 patients potentially left to cure
P45
Reiberger, T; Halilbasic, E; Kontic, M; Eigenbauer, E; Trauner, M: Characteristics of AMA-M2(+) and SP100/GP210(+) primary biliary cholangitis (PBC) at diagnosis and their impact on prognosis
P46
Fürschuß, L; Rainer, F; Portugaller, RH; Fickert, P; Stadlbauer, V: A novel score to predict outcome after transjugular intrahepatic portosystemic shunt for refractory ascites (TAS score)
P47
Mandorfer, M; Thaler, J; Hell, L; Schwabl, P; Bucsics, T; Scheiner, B; Quehenberger, P; Ay, C; Nieuwland, R; Pabinger, I; Lisman, T; Reiberger, T: Intraperitoneal activation of the coagulation system via tissue factor-exposing extracellular vesicles and enhanced fibrinolysis in patients with advanced chronic liver disease and ascites
P48
Riedl, F; Stättermayer, M; Pfisterer, N; Trauner, M; Mayer, A; Reiberger, T; Maieron, A: AUSTROBAND: A prospective register of cirrhotic patients with acute variceal bleeding at the UK Sankt Pölten, an update
P49
Razpotnik, M; Bota, S; Wimmer, P; Hackl, M; Lesnik, G; Alber, H; Peck-Radosavljevic, M: Early detection of cirrhotic cardiomyopathy using myocardial strain imaging and its correlation to liver stiffness and severity of liver disease – a pilot study
P50
Paternostro, R; Staufer, K; Traussnigg, S; Stättermayer, A; Halilbasic, E; Keritam, O; Stift, J; Prager, G; Munda, P; Ferenci, P; Trauner, M: The HSD17B13:TA (rs72613567) splice variant protects against severity of non-alcoholic fatty liver disease but not fibrosis
P51
Paternostro, R; Lampichler, K; Bardach, C; Asenbaum, U; Landler, C; Mandorfer, M; Schwarzer, R; Trauner, M; Reiberger, T; Ferlitsch, A: The value of different CT-based methods for diagnosing sarcopenia and predicting mortality in patients with cirrhosis
P52
Scheiner, B; Kirstein, MM; Hucke, F; Finkelmeier, F; Schulze, K; von Felden, J; Koch, S; Schwabl, P; Hinrichs, JB; Waneck, F; Waidmann, O; Reiberger, T; Müller, C; Sieghart, W; Trauner, M; Weinmann, A; Wege, H; Trojan, J; Peck-Radosavljevic, M; Vogel, A; Pinter, M: PD-1 targeted immunotherapy in advanced hepatocellular carcinoma: efficacy and safety data from an international multicenter real-world cohort
P53
Bota, S; Thoma, B; Aigner, E; Bodlaj, G; Hametner, S; Schleischitz, A; Hucke, F; Zoller, H; Schöfl, R; Püspök, A; Peck-Radosavljevic, M: Experience with obeticholic acid in patients with primary biliary cholangitis – multicentric Austrian analysis
P54
Semmler, G; Simbrunner, B; Scheiner, B; Schwabl, P; Paternostro, R; Bucsics, T; Stättermayer, AF; Bauer, D; Pinter, M; Ferenci, P; Trauner, M; Mandorfer, M; Reiberger, T: Impact of farnesoid X receptor (FXR) polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension
P55
Semmler, G; Scheiner, B; Maurer, F; Trauner, M; Mandorfer, M; Reiberger, T: Prevalence of and risk factors for anemia in patients with advanced chronic liver disease
P56
Semmler, G; Wöran, K; Scheiner, B; Unger, L; Paternostro, R; Stift, J; Schwabl, P; Bucsics, T; Stättermayer, AF; Pinter, M; Trauner, M; Mandorfer, M; Reiberger, T: Reliability criteria for controlled attenuation parameter (CAP) for assessing hepatic steatosis using transient elastography
P57
Urak, C; Bota, S; Razpotnik, M; Hucke, F; Megymorecz, S; Peck-Radosavljevic, M: Value of Hitachi Shear Wave Elastography for non-invasive evaluation of liver fibrosis and complication of cirrhosis
P58
Bota, S; Razpotnik, M; Hucke, F; Flatscher, K; Urak, C; Penz-Österreicher, M; Peck-Radosavljevic, M: Performance and complications rate of liver biopsies performed by trainees in a newly established Hepatology Department
P59
Bucsics, T; Schoder, M; Mandorfer, M; Schwabl, P; Karnel, F; Peck-Radosavljevic, M; Trauner, M; Reiberger, T: Transjugular intrahepatic portosystemic shunt implantation improves renal function in patients with ascites
P60
Bauer, DJ; Bucsics, T; Chromy, D; Simbrunner, B; Jachs, M; Schwabl, P; Mandorfer, M; Reiberger, T: Point shear wave elastography by ElastPQ accurately stages hepatic fibrosis in patients with NAFLD: A prospective, multicentric study
P61
Schaefer, B; Viveiros, A; Tilg, H; Zoller, H: Low serum ceruloplasmin concentration is common in patients with cirrhosis and a MELD independent predictor of liver transplantation or death
P62
Fuchs, CD; Mlitz, V; Tardelli, M; Remetic, J; Menz, M; Paumgartner, G; Wolfrum, S; Wahlström, A; Stahlmann, M; Scharnagl, H; Stojakovic, T; Wolfrum, C; Marschall, H; Trauner, M: Absence of BSEP (ABCB11) protects MDR2 (ABCB4) KO mice from cholestatic liver and bile duct injury through anti-inflammatory bile acid composition and signaling
P63
Schmidbauer, C; Schütz, A; Schwanke, C; Schubert, R; Luhn, J; Gutic, E; Pirker, R; Lang, T; Haltmayer, H; Gschwantler, M: Interim results of an ongoing Project to eliminate chronic hepatitis C in People who inject drugs (PWID) with ongoing intravenous drug use and a high risk of non-adherence to direct-acting antivirals (DAA) in Vienna
P64
Horvath, A; Durdevic, M; Leber, B; di Vora, KG; Rainer, F; Douschan, P; Krones, E; Spindelböck, W; Baumann-Durchschein, F; Zollner, G; Stauber, R; Fickert, P; Stiegler, P; Stadlbauer, V: The modulation of the gut microbiome during a multispecies probiotic intervention in compensated cirrhosis
P65
Borbath, I; Kudo, M; Finn, RS; Galle, PR; Llovet, JM; Blanc, J; Okusaka, T; Chau, I; Cella, D; Peck-Radosavljevic, M; Girvan, A; Gable, J; Bowman, L; Abada, P; Hsu, Y; Zhu, AX: Efficacy, safety, and cancer-related symptoms in patients with hepatocellular carcinoma with alpha-fetoprotein ≥400 ng/ml: A pooled analysis from REACH and REACH-2 studies
P66
Gschwantler, M; Hametner, S; Maieron, A; Peck-Radosavljevic, M; Stauber, R; Wenter, C; Zoller, H; Axmann, S; Stremnitzer, C; Hofer, H: Health Related Quality of Life and Healthcare Resource Utilization in chronic HCV patients under the Glecaprevir/Pibrentasvir Regimen: Interim-Analysis of the Austrian CONFIRMATION Study
P67
Effenberger, M; Grabherr, F; Enrich, B; Grander, C; Niederreiter, L; Zoller, H; Tilg, H: IL-37 correlates with MELD Score & thrombocytopenia in patients with liver cirrhosis
P68
Severgnini, L; Peters, PG; Rumpold, HF; Wahl, A; Bergmeister, P; Fend, L; Flatz, T; Malin, M: Eradication of HCV Infection in Vorarlberg with DAA Therapy. Data about the period between 2015 and 2019
P69
Schmidbauer, C; Chromy, D; Schmidbauer, V; Mandorfer, M; Scheiner, B; Schwabl, P; Bucsics, T; Paternostro, R; Simbrunner, B; Rieger, A; Holzmann, H; Gschwantler, M; Trauner, M; Reiberger, T: Prevalence of non-alcoholic fatty liver disease (NAFLD) among HIV+ individuals in Vienna
P70
Mayr, F; Amrein, K; Tawdrous, M; Spindelböck, W; Stadlbauer-Köllner, V: Osteoporose bei sekundär sklerosierenden Cholangitis nach kritischer Erkrankung
P71
Viveiros, A; Schäfer, B; Höppner, M; Finkenstedt, A; Kremser, C; Plaikner, M; Henninger, B; Franzenburg, S; Franke, A; Tilg, H; Zoller, H: High pre-test likelihood for non-HFE mutations through full exome sequencing in patients with hepatic iron overload
P72
Viveiros, A; Schäfer, B; Finkenstedt, A; Tilg, H; Tilg, H: Diagnostic and prognostic accuracy of fibroscan and FIB-4 in hyperferritinemia and hemochromatosis
P73
Komarova, I; Leber, B; Horvath, A; Posch, A; Streit, A; Spindelboeck, W; Stiegler, P; Stauber, R; Stadlbauer, V: Neutrophil function changes are associated with hemolysis in HCV patients receiving DAA treatment
P74
Mueller, E; Huber-Schönauer, U; Strebinger, G; Feldman, A; Datz, C; Aigner, E: Biochemical liver tests reflect the genetic risk for fatty liver with increasing body weight but not with alcohol consumption
P75
Remetic, J; Mlitz, V; Kunczer, V; Scharnagl, H; Stojakovic, T; Fuchs, CD; Trauner, M: Loss of bile salt export pump (Bsep/Abcb11) aggravates lipopolysaccharide induced hepatic inflammation in mice
P76
Tajibayev, T; Baimakhanov, B; Medeubekov, U; Enin, Y; Isamatov, B: Results of liver transplantation in case of hepatocellular carcinoma
P77
Panzer, M; Viveiros, A; Baumgartner, N; Schaefer, B; Effenberger, M; Obholzer, L; Tilg, H; Zoller, H: A cellular disease model for autosomal dominant ferroportin gene mutations
P78
Niederreiter, M; Niederreiter, L; Schmiderer, A; Zoller, H; Tilg, H; Djanani, A: Liver Metastasis in solitary fibrous tumors (Hemangioperizytoma) – A case series
P79
Kallab, T; Schäfer, B; Viveiros, A; Tilg, H; Pfeifer, B; Zoller, H: Epidemiologische Modellierung der Häufigkeit und Diagnoserate der Hämochromatose in Tirol
P80
Zandanell, S; Feldman, A; Strasser, M; Tevini, J; Felder, T; Huber-Schönauer, U; Datz, C; Aigner, E: AMA-positives without PBC and healthy subjects have similar bile acid profiles but are different from PBC patients
P81
Höfler, J; Huber, V; Dinkhauser, P; Gattringer, R; Rauch Parzer, S; Höbling, W; Hofer, H: Toxocariasis als seltene Ursache von multiplen Leberrundherden